TABLE 4.
Development of Primary Endpoints
Primary Endpoints | UDCA | Placebo |
---|---|---|
Death | 5 | 3 |
Liver Transplant | 11 | 5 |
Minimal Listing Criteria for Liver Transplant | 13 | 10 |
Development of Cirrhosis | 6 | 4 |
Esophageal and/or Gastric Varices | 15 | 5 |
Cholangiocarcinoma | 2 | 2 |
Total Endpoints | 52 | 29 |
Number of Patients Reaching a Primary Endpoint | 30 | 19 |
Number of Patients Reaching Death, OLT, Minimal Criteria Listing | 22 | 15 |